Using individual biomarkers to improve lymphoma treatment

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study focuses on patients diagnosed with specific types of lymphomas, including diffuse large B-cell lymphoma, Hodgkin's lymphoma, and follicular lymphoma. It aims to enhance treatment strategies by utilizing high-throughput molecular techniques to identify tumor genotypes and individual biomarkers. The approach involves blood sampling and the use of PET imaging to optimize treatment plans based on patient responses. By integrating these methods, the study seeks to improve patient management and outcomes during and after treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Person who has not opposed to their inclusion in the trial
* Confirmation of the diagnosis of one of the lymphomas (DGLBL, LF, classic LH, LT or LCM) according to the WHO 2016 international classification (Smerdlow et al, 2016)
* Patients not currently taking treatment for their haemopathy (or who have received corticosteroid therapy alone within 14 days prior to the 1st sampling, dose limited to 500mg total)
* Patients requiring systemic treatment within 30 days of screening

Exclusion Criteria:

* Person subject to legal protection (curatorship, guardianship)
* Person under partial judicial control
* Pregnant, parturient or breastfeeding woman
* Adult incapable or incapable to express his or her non-opposition
* Minor
* Localized lymphoma treated by surgery and/or localized radiotherapy

Where it's running

• Chu Dijon Bourgogne
  Dijon, France Recruiting

Study contacts

• Study coordinator: Cédric ROSSI
• Email: cedric.rossi@chu-dijon.fr
• Phone: 0380295041

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Selinexor with high-dose methotrexate, rituximab, and low-dose whole-brain radiotherapy for newly diagnosed CNS lymphoma patients who can't have transplant

  We will test whether adding oral selinexor to high-dose methotrexate and rituximab followed by low-dose whole-brain radiotherapy can help people with newly diagnosed central nervous system lymphoma who are not candidates for stem cell transplant.

  Recruiting Phase 2 Second Affiliated Hospital of Soochow University · Suzhou · NCT07002099

• Treatment for adults with relapsed or refractory B-cell lymphomas using CAR T-cell therapy

  This study is testing a new CAR T-cell therapy to see if it can help adults with relapsed or hard-to-treat B-cell lymphomas feel better and improve their condition.

  Recruiting Phase 1 M.D. Anderson Cancer Center · Houston, Texas · NCT05773040

• Collection of tissue samples for cancer research

  This study is collecting tissue samples from adults and kids with cancer to help researchers learn more about the disease and improve treatments.

  Recruiting at 10 sites National Institutes of Health Clinical Center (CC) · Sacramento, California and 16 other locations · NCT00900198

• Collecting samples from patients with HIV and related conditions

  This study is collecting blood and tissue samples from adults with HIV and related cancers to help researchers learn more about these conditions.

  Recruiting National Institutes of Health Clinical Center (CC) · Bethesda, Maryland · NCT00006518

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.